Found: 10
Select item for more details and to access through your institution.
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
- Published in:
- Cancer Imaging, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s40644-022-00513-y
- By:
- Publication type:
- Article
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 2851, doi. 10.1007/s00262-021-02895-7
- By:
- Publication type:
- Article
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1333, doi. 10.1007/s00262-017-2029-4
- By:
- Publication type:
- Article
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1061, doi. 10.1007/s00262-014-1575-2
- By:
- Publication type:
- Article
Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 6, p. 817, doi. 10.1007/s00262-011-1140-1
- By:
- Publication type:
- Article
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02766
- By:
- Publication type:
- Article
Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04374-2
- By:
- Publication type:
- Article
CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including 'find‐me', 'eat‐me', and 'kill‐me' signalling.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 7, p. 1, doi. 10.1111/jcmm.18162
- By:
- Publication type:
- Article
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 11, p. 2607, doi. 10.1002/ijc.26297
- By:
- Publication type:
- Article